What are the recommendations for clinical ASCVD patients who are on maximally tolerated statin therapy and are judged to be at very high risk and have an LDL-C level of 70 mg/dL or higher (1.8 mmol/L)?
It is reasonable to add ezetimibe therapy. IIa B-R Recommendation unchanged from 2018 Cholesterol Guidelines.